Plus   Neg

WSJ : Roche Nears $5 Bln Deal To Buy Spark Therapeutics

Roche Holding AG (RHHBY) is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc. (ONCE), the Wall Street Journal reported citing people familiar with the matter.

A deal for Spark could be announced Monday—if not sooner—at a price tag of nearly $5 billion, the Journal reported. That would represent a big premium, given Spark had a market value of just under $2 billion as of Friday's close.

The Journal reported there was at least one other unidentified bidder for Spark as of Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT